動物用整形外科薬の市場規模、シェア、動向分析レポート：製品タイプ別、動物タイプ別、用途別、投与経路別、最終用途別、セグメント予測、2024年～2030年

動物用整形外科薬市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の動物用整形外科薬の市場規模は、2024年から2030年にかけてCAGR 8.4％を記録し、2030年までには63億7,000万米ドルに達すると予測されています。

再生医療の台頭と、動物医療における関節内補充療法製品の採用の増加が、市場成長の主な要因です。Boehringer Ingelheimと米国動物病院協会（AAHA）が実施した調査によると、2022年には犬の5頭に1頭、すなわち全犬の20％が生涯に何らかの関節の問題を経験します。大半の動物が変形性関節症（OA）に罹患するのは、発育性整形外科疾患（DODs）が原因であり、特定の犬種は他の犬種よりも関節が奇形になりやすいです。

獣医療における再生医療の目的は、細胞を用いた治療のような様々なアプローチを含め、病気や損傷を受けた細胞や組織などに正常な機能を回復させることです。この分野では、間葉系間質細胞（MSC）、多血小板血漿（PRP）および自己血清製剤の使用が顕著です。現在、これらの治療法は犬、馬、猫などの動物の腱、靭帯、関節／軟骨治療に用いられています。これらの治療は主に研究に基づいており、さらに具体的な臨床報告が進行中です。現在の用途にかかわらず、この獣医学の一分野は、獣医学的疾患の効果的な治療と管理を約束するものです。

MSC、PRPなどの現在の再生療法は、医薬品のカテゴリーに属します。したがって、FDSはこれらを「細胞ベースの製品」というカテゴリーで規制しています。しかし、これらの治療法については、現在に至るまでFDAの承認は得られておらず、現在の使用はFDAの治験免除に該当します。退行性関節疾患（DJD）やOAでは、関節の摩擦が増加します。ヒアルロン酸のようなビスコサプリメントは、動物の滑膜関節に関節内注射され、関節をさらに潤滑にして摩擦を減らし、スムーズな動きを助ける。このような取り組みは、動物用整形外科薬疾患の効果的な管理に役立つと期待されており、市場成長を牽引しています。

動物用整形外科薬市場レポート・ハイライト

• 医薬品セグメントは、動物用整形外科薬合併症の治療におけるNSAIDS、ステロイドなどの製品の高い採用により、2023年に51.8%以上の最も高い収益シェアを占めました。
• 犬セグメントは2024年から2030年にかけて最も速いCAGRで成長すると予想されています。
• OAセグメントは2023年に42.0%の最大市場シェアを占めました。関節炎症/疼痛セグメントは、2024年から2030年にかけて最も速いCAGRが予測されています。
• ヒアルロン酸のようなビスコサプリメントの使用や、獣医学的合併症における幹細胞治療の採用が増加していることが、市場成長に寄与しています。
• 北米は、変形性関節症の有病率の増加、設備の整った獣医療インフラ、質の高い動物ケアに対する政府の支援、米国におけるペットの飼育率の高さなどの要因により、市場をリードしています。
• 2022年8月、米国はAfrivet Southern Africa Proprietary Limitedを買収しましたが、これは地理的フットプリントを拡大するためのBimedaの継続的な拡大プログラムの一環です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 動物用整形外科薬市場の変数、動向、および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 動物用整形外科薬市場分析ツール
  • ポーターの分析
  • PESTEL分析

第4章 動物用整形外科薬市場：製品タイプの推定・動向分析

• セグメントダッシュボード
• 動物用整形外科薬市場：ソリューション変動分析、2023年・2030年
• 生物製剤
  • 生物製剤市場収益推計と予測、2018年～2030年
• 粘性サプリメント
  • 粘性サプリメント市場収益推計と予測、2018年～2030年
• 医薬品
  • 医薬品市場収益推計と予測、2018年～2030年

第5章 動物用整形外科薬市場：動物タイプの推定・動向分析

• セグメントダッシュボード
• 動物用整形外科薬市場：技術変動分析、2023年・2030年
• 犬科
  • 犬科市場収益推計と予測、2018年～2030年
• ネコ科
  • ネコ科市場収益推計と予測、2018年～2030年
• 馬
  • 馬市場収益推計と予測、2018年～2030年
• 牛
  • 牛市場収益推計と予測、2018年～2030年
• 豚
  • 豚市場収益推計と予測、2018年～2030年
• その他
  • その他の市場収益推計と予測、2018年～2030年

第6章 動物用整形外科薬市場：用途の推定・動向分析

• セグメントダッシュボード
• 動物用整形外科薬市場：技術変動分析、2023年・2030年
• 変形性関節症
  • 変形性関節症市場収益推計と予測、2018年～2030年
• 変形性関節疾患（DJD）
  • 変形性関節疾患
• 関節炎症/痛み
  • 関節炎症/痛み市場収益推計と予測、2018年～2030年
• その他の用途
  • その他の用途市場収益推計と予測、2018年～2030年

第7章 動物用整形外科薬薬市場：投与経路の推定・動向分析

• セグメントダッシュボード
• 動物用整形外科薬市場：技術変動分析、2023年・2030年
• 経口
  • 経口市場収益推計と予測、2018年～2030年
• 非経口
  • 非経口薬市場収益推計と予測、2018年～2030年
• 局所
  • 局所市場収益推計と予測、2018年～2030年

第8章 動物用整形外科薬市場：最終用途推定・動向分析

• セグメントダッシュボード
• 動物用整形外科薬市場：最終用途の変動分析、2023年・2030年
• 動物病院
  • 動物病院市場収益推計と予測、2018年～2030年
• 動物クリニック
  • 動物クリニック市場収益推計と予測、2018年～2030年
• その他
  • その他の市場収益推計と予測、2018年～2030年

第9章 動物用整形外科薬市場：地域推定・動向分析

• 動物用整形外科薬市場シェア、地域別、2023年・2030年
• 北米
  • 北米の動物用整形外科薬市場推計・予測、2018年～2030年
  • 米国
  • カナダ
• 欧州
  • 欧州の動物用整形外科薬市場推計・予測、2018年～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • アジア太平洋地域の動物用整形外科薬市場推計・予測、2018年～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの動物用整形外科薬市場推計・予測、2018年～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカの動物用整形外科薬市場推計・予測、2018年～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業の分類
• 企業の市場シェア分析
• 企業ヒートマップ分析
• 戦略マッピング
  • 拡大
  • 合併と買収
  • パートナーシップとコラボレーション
  • 新製品の発売
  • 研究開発
• 企業プロファイル
  • Zoetis, Inc.
  • Boehringer Ingelheim
  • Elanco Animal Health
  • American Regent, Inc.
  • Merck Animal Health（Merck &Co. Inc.）
  • Vetoquinol SA
  • Ceva Sante Animale
  • Virbac
  • Biogenesis Bago
  • Ardent Animal Health Llc.
  • Bioiberica SAU
  • PetVivo Holdings, Inc.（Spryng）
  • Contipro AS
  • VetStem, Inc.
  • Enso Discoveries
  • Contura Vet US
  • T-Cyte Therepeutics
  • MEDREGO LLC
  • Bimeda US
  • Hyalogic
  • Hester Biosciences

List of Tables

• Table 1 Veterinary Orthopedic Medicine(Veterinary Orthopedic Medicine) market 2018 - 2030 (USD Million)
• Table 2 Global market estimates and forecasts by region, 2018 - 2030 (USD Million)
• Table 3 Global market estimates and forecasts By Product type, 2018 - 2030 (USD Million)
• Table 4 Global market estimates and forecasts By Animal type, 2018 - 2030 (USD Million)
• Table 5 Global market estimates and forecasts By Application, 2018 - 2030 (USD Million)
• Table 6 Global market estimates and forecasts By Route of Administration, 2018 - 2030 (USD Million)
• Table 7 Global market estimates and forecasts by End-use, 2018 - 2030 (USD Million)
• Table 8 Veterinary Orthopedic Medicine- M&A, collaborations & partnership scenario
• Table 9 Biologics Veterinary Orthopedic Medicine market by region, 2018 - 2030 (USD Million)
• Table 10 Viscosupplements Veterinary Orthopedic Medicine market by region, 2018 - 2030 (USD Million)
• Table 11 Pharmaceuticals Veterinary Orthopedic Medicine market by region, 2018 - 2030 (USD Million)
• Table 12 Veterinary Orthopedic Medicine Canine market by region, 2018 - 2030 (USD Million)
• Table 13 Veterinary Orthopedic Medicine Feline market by region, 2018 - 2030 (USD Million)
• Table 14 Veterinary Orthopedic Medicine Equine market by region, 2018 - 2030 (USD Million)
• Table 15 Veterinary Orthopedic Medicine Cattle market by region, 2018 - 2030 (USD Million)
• Table 16 Veterinary Orthopedic Medicine Swine market by region, 2018 - 2030 (USD Million)
• Table 17 Veterinary orthopedic medicine Osteoarthrtitis market, by use case, 2018 - 2030, (USD Million)
• Table 18 Veterinary Orthopedic Medicine Degenerative Joint Diseases (DJD) market by region, 2018 - 2030 (USD Million)
• Table 19 Veterinary orthopedic medicine Joint Inflammation/Pain market, by region 2018 - 2030, (USD Million)
• Table 20 Veterinary Orthopedic Medicine Oral by region, 2018 - 2030 (USD Million)
• Table 21 Veterinary Orthopedic Medicine Parenteral market by region, 2018 - 2030 (USD Million)
• Table 22 Veterinary Orthopedic Topical market by region, 2018 - 2030 (USD Million)
• Table 23 Veterinary Orthopedic Medicine Veterinary Hospitals market by region, 2018 - 2030 (USD Million)
• Table 24 Veterinary Orthopedic Medicine Veterinary Clinics market by region, 2018 - 2030 (USD Million)
• Table 25 North America Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 26 North America Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 27 North America Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 28 North America Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 29 North America Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 30 U.S. Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 31 U.S. Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 32 U.S. Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 33 U.S. Veterinary Orthopedic Medicine market By Route of Administration, 2018 -
• Table 34 U.S. Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 35 Canada Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 36 Canada Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 37 Canada Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 38 Canada Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 39 Canada Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 40 Mexico Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 41 Mexico Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 42 Mexico Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 43 Mexico Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 44 Mexico Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 45 Europe Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 46 Europe Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 47 Europe Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 48 Europe Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 49 Europe Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 50 Germany Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 51 Germany Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 52 Germany Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 53 Germany Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 54 Germany Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 55 UK Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 56 UK Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 57 UK Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 58 UK Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 59 UK Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 65 China Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 66 China Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 67 China Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 68 China Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 69 China Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 70 Japan Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 71 Japan Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 72 Japan Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 73 Japan Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 74 Japan Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 75 India Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 76 India Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 77 India Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 78 India Veterinary Orthopedic Medicine market By Route of Aministration, 2018 - 2030 (USD Million)
• Table 79 India Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 80 South Koreaa Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 81 South Korea Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 82 South Korea Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 83 South Korea Veterinary Orthopedic Medicine market By Route of Aministration, 2018 - 2030 (USD Million)
• Table 84 South Korea Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 85 Brazil Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 86 Brazil Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 87 Brazil Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 88 Brazil Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 89 Brazil Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
• Table 90 Middle East & Africa Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
• Table 91 Middle East & Africa Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
• Table 92 Middle East & Africa Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
• Table 93 Middle East & Africa Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
• Table 94 Middle East & Africa Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Veterinary Orthopedic Medicine Market Segmentation
• Fig. 2 Disease Epidemiology
• Fig. 3 Information Procurement
• Fig. 4 Data Analysis Models
• Fig. 5 Market Formulation and Validation
• Fig. 6 Data Validating & Publishing
• Fig. 7 Market Snapshot
• Fig. 8 Segment Snapshot (1/2)
• Fig. 9 Segment Snapshot (2/2)
• Fig. 10 Competitive Landscape Snapshot
• Fig. 11 Veterinary Orthopedic Medicine - Market Size and Growth Prospects (USD Million)
• Fig. 12 Veterinary Orthopedic Medicine Market: Industry Value Chain Analysis
• Fig. 13 Veterinary Orthopedic Medicine Market: Market Dynamics
• Fig. 14 Veterinary Orthopedic Medicine Market: PORTER's Analysis
• Fig. 15 Veterinary Orthopedic Medicine Market: PESTEL Analysis
• Fig. 16 Veterinary Orthopedic Medicine Market Share By Product type, 2023 & 2030 (USD Million)
• Fig. 17 Veterinary Orthopedic Medicine Market, By Product type: Market Share, 2023 & 2030
• Fig. 18 Biologics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 19 Viscosupplements Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 20 Pharmaceuticals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 21 Veterinary Orthopedic Medicine Market Share By Animal type, 2023 & 2030 (USD Million)
• Fig. 22 Veterinary Orthopedic Medicine Market, By Animal type: Market Share, 2023 & 2030
• Fig. 23 Canine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 24 Feline Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 25 Equine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 26 Cattle Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 27 Swine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 28 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 29 Veterinary Orthopedic Medicine Market Share By Application, 2023 & 2030 (USD Million)
• Fig. 30 Veterinary Orthopedic Medicine Market, By Application: Market Share, 2023 & 2030
• Fig. 31 Osteoarthritis Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 32 Dengenerative Joint Diseases (DJD) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 33 Joint Inflammaition/Pain Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 34 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 35 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 36 Veterinary Orthopedic Medicine Market Share By Route of Administration, 2023 & 2030 (USD Million)
• Fig. 37 Veterinary Orthopedic Medicine Market, By Route of Administration: Market Share, 2023 & 2030
• Fig. 38 Oral Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 39 Parenteral Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 40 Veterinary Orthopedic Medicine Market, by End-Use: Key Takeaways
• Fig. 41 Veterinary Orthopedic Medicine Market, by End-Use: Market Share, 2023 & 2030
• Fig. 42 Veterinary Hospitals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 43 Veterinary Clinics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 44 Other Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 45 Veterinary Orthopedic Medicine Market Revenue, by Region, 2023 & 2030, (USD Million)
• Fig. 46 Regional Marketplace: Key Takeaways
• Fig. 47 Regional Marketplace: Key Takeaways
• Fig. 48 North America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 U.S. Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Canada Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Europe Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 UK Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
• Fig. 53 Germany Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 France Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Italy Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Spain Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Denmark Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Sweden Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Norway Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Asia Pacific Veterinary Orthopedic Medicine Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 61 China Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Japan Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 63 India Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 South Korea Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Australia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Thailand Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Latin America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Brazil Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Mexico Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Argentina Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 71 MEA Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 72 KSA Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 73 UAE Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 74 South Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Kuwait Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Key Company Categorization
• Fig. 77 Company Market Positioning
• Fig. 78 Key Company Market Share Analysis, 2023
• Fig. 79 Strategic Framework

Veterinary Orthopedic Medicine Market Growth & Trends:

The global veterinary orthopedic medicines market size is anticipated to reach USD 6.37 billion by 2030, registering a CAGR of 8.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing emergence of regenerative medicine and rise in the adoption of viscosupplementation products in veterinary medicine are the major factors contributing to market growth. According to a study conducted by Boehringer Ingelheim and the American Animal Hospital Association (AAHA), in 2022, 1 in 5 dogs i.e., 20% of all dogs experience some joint issue in their lifetime. The majority of animals suffer from Osteoarthritis (OA) because of Developmental Orthopedic Diseases (DODs), with certain breeds more prone to malformed joints than others.

The aim of regenerative medicine in veterinary medicine is to restore normal function to diseased or damaged cells, tissues, etc., including different approaches like cell-based therapies. The use of mesenchymal stromal cells (MSCs), platelet-rich plasma (PRP) & autologous serum products is prominent in this field. Currently, these therapies are used in tendon, ligament, and joint/cartilage treatment in animals like dogs, horses & cats. These treatments are primarily research-based and further concrete clinical reports are under progress. Irrespective of the current use, this branch of veterinary medicine promises effective treatment & management of veterinary diseases.

Current regenerative therapies like MSCs, PRP, etc., fall under the category of drugs. Therefore, FDS regulates them under the category "Cell-based Products"; however, no FDA approval has been given to any of these therapies till now, and the current use falls under FDA investigational exemption. Degenerative Joint Diseases (DJD) and OA cause a rise in friction in the joints. Viscosupplements, such as hyaluronic acid, are intra-articularly injected into the synovial joint of the animal, which further lubricates the joint to reduce friction and assist in smooth movement. Such initiatives are expected to help in the effective management of veterinary orthopedic conditions, thus driving market growth.

Veterinary Orthopedic Medicine Market Report Highlights:

• The pharmaceuticals segment accounted for the highest revenue share of more than 51.8% in 2023 owing to the high adoption of products like NSAIDS, steroids, etc. in the treatment of veterinary orthopedic complications
• The canine segment is expected to grow at the fastest CAGR from 2024 to 2030
• The OA segment held the largest market share of 42.0% in 2023. The joint inflammation/pain segment is anticipated to witness the fastest CAGR from 2024 to 2030
• Use of viscosupplements like hyaluronic acid and rising adoption of stem-cell therapy in veterinary complications contributed to market growth
• North America led the market owing to factors, such as increasing prevalence of osteoarthritis, well-equipped veterinary care infrastructure, government support for quality animal care, and high pet adoption in the U.S.
• In August 2022, Bimeda U.S. acquired Afrivet Southern Africa Proprietary Limited, a part of Bimeda's ongoing expansion program to increase its geographic footprint

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of Primary Research
  • 1.5.1. Data for Primary Interviews in North America
  • 1.5.2. Data for Primary Interviews in Europe
  • 1.5.3. Data for Primary Interviews in Asia Pacific
  • 1.5.4. Data for Primary Interviews in Latin America
  • 1.5.5. Data for Primary Interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Parent Market Analysis (Model 1)
    • 1.7.1.1. Approach 1: Parent Market approach
  • 1.7.2. Company Share Analysis (Model 2)
    • 1.7.2.1. Approach 2: Company Share approach
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Orthopedic Medicine Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Emergence of Regenerative Medicine
    • 3.2.1.2. Increasing Adoption of Viscosupplementation Products in Treatment of Musculoskeletal Disorders
    • 3.2.1.3. Rise in Prevalence of Osteoarthritis and other Degenerative Joint Diseases
    • 3.2.1.4. Rising Adoption of Stem Cell Therapy and Other Biologics in Veterinary Medicine
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Low Penetration of Importance of Veterinary Care in Under-developed Countries
    • 3.2.2.2. Thorough Regulatory Scrutiny
• 3.3. Veterinary Orthopedic Medicine Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining Power of The Suppliers
    • 3.3.1.2. Bargaining Power of the Buyers
    • 3.3.1.3. Threats of Substitution
    • 3.3.1.4. Threats from New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological Landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. Veterinary Orthopedic Medicine Market: Product type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Veterinary Orthopedic Medicine Market: Solution Movement Analysis, USD Million, 2023 & 2030
• 4.3. Biologics
  • 4.3.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Viscosupplements
  • 4.4.1. Viscosupplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Pharmaceuticals
  • 4.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Orthopedic Medicine Market: Animal type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
• 5.3. Canine
  • 5.3.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Feline
  • 5.4.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Equine
  • 5.5.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Cattle
  • 5.6.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Swine
  • 5.7.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Orthopedic Medicine Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
• 6.3. Osteoarthritis
  • 6.3.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Degenerative Joint Disease (DJD)
  • 6.4.1. Degenerative Joint Disease (DJD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Joint Inflammation/Pain
  • 6.5.1. Joint Inflammation/Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Other Applications
  • 6.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Orthopedic Medicine Market: Route of Administration Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
• 7.3. Oral
  • 7.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Parenteral
  • 7.4.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Topical
  • 7.5.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Orthopedic Medicine Market: End-use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Veterinary Orthopedic Medicine Market: End-user Movement Analysis, USD Million, 2023 & 2030
• 8.3. Veterinary Hospitals
  • 8.3.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Veterinary Clinics
  • 8.4.1. Veterinary Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Others
  • 8.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Orthopedic Medicine Market: Regional Estimates & Trend Analysis

• 9.1. Veterinary Orthopedic Medicine Market Share, By Region, 2023 & 2030, USD Million
• 9.2. North America
  • 9.2.1. North America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.2. U.S.
    • 9.2.2.1. Key Country Dynamics
    • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.2.2.3. Competitive Insights
    • 9.2.2.4. U.S. Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.2.3. Canada
    • 9.2.3.1. Key Country Dynamics
    • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.2.3.3. Competitive Insights
    • 9.2.3.4. Canada Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.3. Europe
  • 9.3.1. Europe Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.2. UK
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.2.3. Competitive Insights
    • 9.3.2.4. UK Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.3. Germany
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.3.3. Competitive Insights
    • 9.3.3.4. Germany Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.4. France
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.4.3. Competitive Insights
    • 9.3.4.4. France Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.5. Italy
    • 9.3.5.1. Key Country Dynamics
    • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.5.3. Competitive Insights
    • 9.3.5.4. Italy Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.6. Spain
    • 9.3.6.1. Key Country Dynamics
    • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.6.3. Competitive Insights
    • 9.3.6.4. Spain Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.7. Denmark
    • 9.3.7.1. Key Country Dynamics
    • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.7.3. Competitive Insights
    • 9.3.7.4. Denmark Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.8. Sweden
    • 9.3.8.1. Key Country Dynamics
    • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.8.3. Competitive Insights
    • 9.3.8.4. Sweden Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3.9. Norway
    • 9.3.9.1. Key Country Dynamics
    • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
    • 9.3.9.3. Competitive Insights
    • 9.3.9.4. Norway Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.4. Asia Pacific
  • 9.4.1. Asia Pacific Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. Japan
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.2.3. Competitive Insights
    • 9.4.2.4. Japan Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. China
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.3.3. Competitive Insights
    • 9.4.3.4. China Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. India
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.4.3. Competitive Insights
    • 9.4.4.4. India Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.5. Australia
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.5.3. Competitive Insights
    • 9.4.5.4. Australia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.6. Thailand
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.6.3. Competitive Insights
    • 9.4.6.4. Thailand Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4.7. South Korea
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
    • 9.4.7.3. Competitive Insights
    • 9.4.7.4. South Korea Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5. Latin America
  • 9.5.1. Latin America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. Brazil
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.5.2.3. Competitive Insights
    • 9.5.2.4. Brazil Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Mexico
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.5.3.3. Competitive Insights
    • 9.5.3.4. Mexico Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. Argentina
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Regulatory Landscape/Reimbursement Scenario
    • 9.5.4.3. Competitive Insights
    • 9.5.4.4. Argentina Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.6. Middle East and Africa
  • 9.6.1. Middle East and Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. South Africa
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
    • 9.6.2.3. Competitive Insights
    • 9.6.2.4. South Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. Saudi Arabia
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
    • 9.6.3.3. Competitive Insights
    • 9.6.3.4. Saudi Arabia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. UAE
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
    • 9.6.4.3. Competitive Insights
    • 9.6.4.4. UAE Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. Kuwait
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
    • 9.6.5.3. Competitive Insights
    • 9.6.5.4. Kuwait Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis by Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Market Share Analysis
• 10.4. Company Heat Map Analysis
• 10.5. Strategy Mapping
  • 10.5.1. Expansion
  • 10.5.2. Mergers & Acquisition
  • 10.5.3. Partnerships & Collaborations
  • 10.5.4. New Product Launches
  • 10.5.5. Research And Development
• 10.6. Company Profiles
  • 10.6.1. Zoetis, Inc.
    • 10.6.1.1. Participant's Overview
    • 10.6.1.2. Financial Performance
    • 10.6.1.3. Product Benchmarking
    • 10.6.1.4. Recent Developments
  • 10.6.2. Boehringer Ingelheim
    • 10.6.2.1. Participant's Overview
    • 10.6.2.2. Financial Performance
    • 10.6.2.3. Product Benchmarking
    • 10.6.2.4. Recent Developments
  • 10.6.3. Elanco Animal Health
    • 10.6.3.1. Participant's Overview
    • 10.6.3.2. Financial Performance
    • 10.6.3.3. Product Benchmarking
    • 10.6.3.4. Recent Developments
  • 10.6.4. American Regent, Inc.
    • 10.6.4.1. Participant's Overview
    • 10.6.4.2. Financial Performance
    • 10.6.4.3. Product Benchmarking
    • 10.6.4.4. Recent Developments
  • 10.6.5. Merck Animal Health (Merck & Co. Inc.)
    • 10.6.5.1. Participant's Overview
    • 10.6.5.2. Financial Performance
    • 10.6.5.3. Product Benchmarking
    • 10.6.5.4. Recent Developments
  • 10.6.6. Vetoquinol S.A.
    • 10.6.6.1. Participant's Overview
    • 10.6.6.2. Financial Performance
    • 10.6.6.3. Product Benchmarking
    • 10.6.6.4. Recent Developments
  • 10.6.7. Ceva Sante Animale
    • 10.6.7.1. Participant's Overview
    • 10.6.7.2. Financial Performance
    • 10.6.7.3. Product Benchmarking
    • 10.6.7.4. Recent Developments
  • 10.6.8. Virbac
    • 10.6.8.1. Participant's Overview
    • 10.6.8.2. Financial Performance
    • 10.6.8.3. Product Benchmarking
    • 10.6.8.4. Recent Developments
  • 10.6.9. Biogenesis Bago
    • 10.6.9.1. Participant's Overview
    • 10.6.9.2. Financial Performance
    • 10.6.9.3. Product Benchmarking
    • 10.6.9.4. Recent Developments
  • 10.6.10. Ardent Animal Health Llc.
    • 10.6.10.1. Participant's Overview
    • 10.6.10.2. Financial Performance
    • 10.6.10.3. Product Benchmarking
    • 10.6.10.4. Recent Developments
  • 10.6.11. Bioiberica S.A.U
    • 10.6.11.1. Participant's Overview
    • 10.6.11.2. Financial Performance
    • 10.6.11.3. Product Benchmarking
    • 10.6.11.4. Recent Developments
  • 10.6.12. PetVivo Holdings, Inc. (Spryng)
    • 10.6.12.1. Participant's Overview
    • 10.6.12.2. Financial Performance
    • 10.6.12.3. Product Benchmarking
    • 10.6.12.4. Recent Developments
  • 10.6.13. Contipro A.S.
    • 10.6.13.1. Participant's Overview
    • 10.6.13.2. Financial Performance
    • 10.6.13.3. Product Benchmarking
    • 10.6.13.4. Recent Developments
  • 10.6.14. VetStem, Inc.
    • 10.6.14.1. Participant's Overview
    • 10.6.14.2. Financial Performance
    • 10.6.14.3. Product Benchmarking
    • 10.6.14.4. Recent Developments
  • 10.6.15. Enso Discoveries
    • 10.6.15.1. Participant's Overview
    • 10.6.15.2. Financial Performance
    • 10.6.15.3. Product Benchmarking
    • 10.6.15.4. Recent Developments
  • 10.6.16. Contura Vet US
    • 10.6.16.1. Participant's Overview
    • 10.6.16.2. Financial Performance
    • 10.6.16.3. Product Benchmarking
    • 10.6.16.4. Recent Developments
  • 10.6.17. T-Cyte Therepeutics
    • 10.6.17.1. Participant's Overview
    • 10.6.17.2. Financial Performance
    • 10.6.17.3. Product Benchmarking
    • 10.6.17.4. Recent Developments
  • 10.6.18. MEDREGO LLC
    • 10.6.18.1. Participant's Overview
    • 10.6.18.2. Financial Performance
    • 10.6.18.3. Product Benchmarking
    • 10.6.18.4. Recent Developments
  • 10.6.19. Bimeda U.S.
    • 10.6.19.1. Participant's Overview
    • 10.6.19.2. Financial Performance
    • 10.6.19.3. Product Benchmarking
    • 10.6.19.4. Recent Developments
  • 10.6.20. Hyalogic
    • 10.6.20.1. Participant's Overview
    • 10.6.20.2. Financial Performance
    • 10.6.20.3. Product Benchmarking
    • 10.6.20.4. Recent Developments
  • 10.6.21. Hester Biosciences
    • 10.6.21.1. Participant's Overview
    • 10.6.21.2. Financial Performance
    • 10.6.21.3. Product Benchmarking
    • 10.6.21.4. Recent Developments